The client aimed to evaluate time to event outcomes, including overall survival and progression free survival, in breast cancer patients receiving different treatment regimens. The objective was to identify significant risk factors, compare therapeutic effectiveness, and generate statistical evidence to support clinical decision making.
Our team performed structured survival analysis using Kaplan Meier curves to estimate survival probabilities across treatment groups and calculated hazard ratios to quantify treatment effects while assessing statistical significance. Subgroup analyses were conducted based on disease stage and patient characteristics. The findings were documented in comprehensive R Markdown reports to ensure clarity, reproducibility, and regulatory ready presentation.
Targeted therapy significantly improved survival compared to chemotherapy alone. The analysis provided strong quantitative evidence of treatment effectiveness, supported personalized treatment strategies, and informed future clinical trial design. These insights contributed to improved patient outcomes and more data driven oncology care.
The client aimed to evaluate time to event outcomes, including overall survival and progression free survival, in breast cancer patients receiving different treatment regimens. The objective was to identify significant risk factors, compare therapeutic effectiveness, and generate statistical evidence to support clinical decision making.
Our team performed structured survival analysis using Kaplan Meier curves to estimate survival probabilities across treatment groups and calculated hazard ratios to quantify treatment effects while assessing statistical significance. Subgroup analyses were conducted based on disease stage and patient characteristics. The findings were documented in comprehensive R Markdown reports to ensure clarity, reproducibility, and regulatory ready presentation.
Targeted therapy significantly improved survival compared to chemotherapy alone. The analysis provided strong quantitative evidence of treatment effectiveness, supported personalized treatment strategies, and informed future clinical trial design. These insights contributed to improved patient outcomes and more data driven oncology care.
Headquartered in New Jersey, Rang Technologies has dedicated over a decade delivering innovative solutions and best talent to help businesses get the most out of the latest technologies in their digital transformation journey. Rang Technologies has grown to become a global leader in Analytics, Data Science, Artificial Intelligence, Machine Learning, Salesforce CRM, Cloud, DevOps, Internet of Things (IoT), Cybersecurity, IT Consulting and Staffing, and Corporate Training. Our clients, which include Fortune 500 to Start-up companies, come from a wide array of industries, including pharmaceuticals, healthcare, retail, technology, BFSI, media, automobile, manufacturing, and several others. Our clients know they can rely on Rang Technologies to deliver customized and comprehensive digital solutions and talent to complement their business and technical objectives.
